Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGreggs Regulatory News (GRG)

Share Price Information for Greggs (GRG)

Share Price is delayed by 15 minutes
Get Live Data
1,648.00    -13.00 (-0.78%)
Bid:
1,639.00
Ask:
1,644.00
Spread: 5.00 (0.305%)
Market Cap: £1.68b
GRG Live PriceLast checked at - London Stock Exchange

Intraday Greggs Share Chart

Directorate Change

27 Apr 2022 07:00

RNS Number : 4419J
Greggs PLC
27 April 2022
 

 

 

 

GREGGS plc

 

Board Changes

The Board of Greggs plc announces that it has appointed Lynne Weedall as an independent non-executive director, with effect from 17 May 2022. Lynne will join the Board immediately following the close of the Annual General Meeting currently scheduled on that date.

Lynne is an experienced People and Business Transformation executive, having held senior positions most recently at Selfridges, and before that at Carphone Warehouse. Throughout her executive career Lynne has been involved in and led transformational projects in several of the companies she has worked for, which have also included Whitbread, and BUPA.

Lynne is currently the senior independent non-executive director and Remuneration Committee Chair at Dr. Martens plc, and at Stagecoach plc, and on 3 May 2022 is due to join the Board of Softcat plc as non-executive director and Chair of the Remuneration Committee. Lynne is also a non-executive director and Nominations Committee chair at Treatt plc. Lynne was previously a non-executive director and Remuneration Committee Chair of Greene King plc from 2012 until 2019 and William Hill plc from 2019 until April 2021.

The Board intends that Lynne will be appointed as Chair of the Remuneration Committee when Helena Ganczakowski steps down from the Board in 2023.

Ian Durant, Chair of Greggs, said "We are delighted that such an experienced non-executive director has accepted our invitation to join the Board. Lynne brings with her extensive experience of HR & transformational change, and will add significant value to our Board during this transitional phase and beyond".

 

Listing Rule 9.6.13R (1) to (6) Disclosure

There are no further matters required by paragraphs 9.6.13R (1) to (6) of the Listing Rules to be disclosed in relation to Lynne Weedall.

ENDS

ENQUIRIES:

 

 

Greggs plc

Hudson Sandler

Roger Whiteside, Chief Executive

Richard Hutton, Finance Director

Hattie Dreyfus / Nick Moore / Sophie Miles

Tel: 0191 281 7721

 

Tel: 020 7796 4133

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPURWCUPPGMQ
Date   Source Headline
26th Jun 202311:37 amRNSDirector/PDMR Shareholding
14th Jun 20237:52 amRNSHolding(s) in Company
5th Jun 20233:53 pmRNSDirector/PDMR Shareholding
1st Jun 20234:50 pmRNSTotal Voting Rights
1st Jun 20237:26 amRNSDirector Declaration
22nd May 20232:57 pmRNSDirector/PDMR Shareholding
22nd May 20232:53 pmRNSDirector/PDMR Shareholding
18th May 20233:44 pmRNSHolding(s) in Company
17th May 20234:14 pmRNSResult of AGM
17th May 20233:38 pmRNSDirectorate Change
16th May 20232:18 pmRNSHolding(s) in Company
16th May 20237:00 amRNSTrading Update
2nd May 202310:38 amRNSTotal Voting Rights
26th Apr 20239:22 amRNSNotice of Trading Update
18th Apr 20237:00 amRNSAdditional Listing
11th Apr 20234:34 pmRNSAnnual Financial Report
11th Apr 20239:20 amRNSGreggs Publishes Annual Sustainability Report
3rd Apr 20238:31 amRNSDirector/PDMR Shareholding
3rd Apr 20238:20 amRNSTotal Voting Rights
15th Mar 202311:34 amRNSDirector Declaration
7th Mar 20237:00 amRNSAppointment of Non-Executive Director
7th Mar 20237:00 amRNSPreliminary Results
1st Mar 20239:18 amRNSTotal Voting Rights
9th Feb 20237:00 amRNSNotice of Preliminary Results
1st Feb 20237:00 amRNSTotal Voting Rights
27th Jan 20232:05 pmRNSHolding(s) in Company
26th Jan 20232:07 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSQ4 Trading Update
3rd Jan 202312:26 pmRNSTotal Voting Rights
5th Dec 20227:00 amRNSNotice of Trading Update
1st Dec 20224:17 pmRNSTotal Voting Rights
1st Nov 202210:21 amRNSTotal Voting Rights
13th Oct 202211:15 amRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSQ3 Trading Update
3rd Oct 202210:12 amRNSTotal Voting Rights
21st Sep 20224:59 pmRNSHolding(s) in Company
20th Sep 20223:41 pmRNSNotice of Trading Update
1st Sep 20229:48 amRNSTotal Voting Rights
2nd Aug 20221:06 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSInterim Results
2nd Aug 20227:00 amRNSAppointment of Chair Designate
1st Aug 20226:17 pmRNSTotal Voting Rights
18th Jul 20222:10 pmRNSDirector/PDMR Shareholding
18th Jul 20222:09 pmRNSDirector/PDMR Shareholding
5th Jul 20224:17 pmRNSHolding(s) in Company
30th Jun 20222:23 pmRNSTotal Voting Rights
28th Jun 20227:00 amRNSNotice of Interim Results
27th Jun 20223:32 pmRNSDirector Declaration
22nd Jun 20229:57 amRNSDirector/PDMR Shareholding
21st Jun 202212:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.